AI Article Synopsis

  • High breast cancer (BC) mortality in Africa is largely due to late diagnoses, which are influenced by inconsistent barriers identified in various studies across the continent.
  • A meta-analysis of research from 2000 to 2020 found significant associations between delayed presentation/advanced-stage diagnosis and factors such as low education levels, lack of breast self-examination practices, and varying patient ages across different regions.
  • There is a pressing need for targeted strategies to promote early detection and treatment of BC, particularly addressing educational gaps and increasing awareness of breast health practices.

Article Abstract

Background/objective: Breast cancer (BC) mortality is exceptionally high in Africa due to late presentation and advanced-stage diagnosis. Previous studies examining barriers to early BC presentation are markedly inconsistent, showing conflicting findings within and between African regions, making resource allocation and designing interventional campaigns challenging. Our objective was to assess the strength or magnitude of the association between determinants/risk factors and delayed presentation/advanced-stage diagnosis of BC in Africa.

Methods: Electronic searches in PubMed, AJOL, Google, ResearchGate, ScienceDirect, and PubMed Central found eligible articles between 2000 and 2020. The meta-analytical procedure in Meta-XL used the quality effect model. I-squared (I2) above 75% indicated high heterogeneity. The summary effect size was the odds ratio with 95% confidence intervals.

Results: The effect of socio-economic and demographic determinants on delay varies across African regions. Low level of education (1.63, 95% CI 1.01-2.63), and not performing breast self examination (BSE) (13.59, 95% CI 3.33-55.4) were significantly associated with delayed presentation. Younger patients had more significant delays in West Africa (WA, 1.41, 95%CI 1.08-1.85), and the reverse occurred in North Africa (0.68, 95%CI 0.48-0.97). Lack of BC knowledge (1.59, 95% CI 1.29-1.97), not performing BSE, or no history of undergoing clinical breast examination (CBE) (2.45, 95% CI 1.60-3.40), were associated with advanced-stage disease at diagnosis. Older patients had significantly more advanced disease in WA, and the reverse occurred in South Africa. Aggressive molecular BC subtypes [Triple negative (OR 1.62, 95% CI 1.27-2.06) or HER2 positive (1.56, 95% CI 1.10-2.23)] were significant determinants of advanced-stage diagnosis.

Conclusion: Promoting early presentation and reducing advanced-stage BC throughout Africa should focus on modifiable factors, including providing quality education, improving breast health awareness and BC knowledge, and developing strategies to increase BSE and CBE. Interventions targeting socio-demographic determinants should be context-specific.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8325140PMC
http://dx.doi.org/10.31557/APJCP.2021.22.4.1007DOI Listing

Publication Analysis

Top Keywords

delayed presentation
8
presentation advanced-stage
8
advanced-stage diagnosis
8
breast cancer
8
early presentation
8
african regions
8
breast examination
8
reverse occurred
8
95%
7
africa
6

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!